Search results

  1. Murph

    Poisoned Feeling

    They only recently discovered the brain's drainage system, a bunch of tubes that has been labelled the glymphatic system. Its function correlates with cerebral blood flow. If we don't get enough blood into the brain, we can't get the rubbish out of there. Cerebral blood flow is very much...
  2. Murph

    Malic acid supplement, sumac

    That's quite a good blinding technique, and a decent result! I'd like to see more data but it certainly appears as though Malic acid works for you. If hope the result continues and if there is a subset, I wonder how big it is! However I worry sometimes about the reception for simple treatments...
  3. Murph

    Asymmetrical glymphatic dysfunction in patients with long Covid associated neurocognitive impairment- correlation with BBB disruption, 2025, Chaganti+

    Been thinking a lot about cerebral blood flow, which is plainly impaired in POTS. I'm fascinated by the comorbidity of POTS and me/cfs. Could diverse symptoms share a common cause in some cases? I sometimes can't put down occam's razor, even when I am at risk of cutting my finger. Anyway, I...
  4. Murph

    Reversible reduction in brain myelin content upon marathon running, 2025, Ramos-Cabrer et al.

    This is a fascinating hypothesis. Are there other types of tissue that serve as reserve energy? As I understand we use up phosphocreatine, and glycogen, then the body tries to burn fat. But perhaps other things are being burnt too and they're meant to be used only in crisis? Muscle is one...
  5. Murph

    Do you believe that “viral persistence” is the cause of ongoing MECFS and LC?

    At the risk of being pedantic on the any .... Hwang's study on the patient with Li Fraumeni and mecfs showed this. "Measuring the regeneration of phosphocreatine (PCr) after its utilization by exercise in skeletal muscle using 31P-MRS can noninvasively assess mitochondrial ATP synthesis...
  6. Murph

    Preprint An interorgan neuroimmune circuit promotes visceral hypersensitivity, 2025, Kim+

    You have to love when vague, general pain symptoms end up having an identifiable neural basis. Another one taken from our old friends the psychologists by good science.
  7. Murph

    Preprint Demonstrating the potential of untargeted hair proteomics for personalized biomarkers in stress-associated disorders, 2025, Sicorello et al

    love it. I'm all for exploration of samples that are easiest to collect, least invasive, easiest to send by mail. That's how you cut costs and lift sample size. Obviously if it shows nothing it's not worth it but we've recently seen some interesting results in saliva and urine. Not everything...
  8. Murph

    Open Master’s Thesis: seeking perceptions about chronic fatigue syndrome in the workplace from working people who both have and do not have ME/CFS

    I found that survey to be a bit of a pigsty. Didn't ask any questions that might have got information from me, and I have quite an extensive employment history during mecfs. Garbage going in ....
  9. Murph

    News from Australia

    Emerge ran a competition for the best story about Long covid. the winner was Hayley Gleeson, published at the ABC: https://www.abc.net.au/news/2024-06-16/children-with-long-covid-dismissed-doctors-myth-virus-harmless/103959078 your boy murph was a runner-up in the comp.
  10. Murph

    Geographic Disparities and Emerging Hotspot Trends of Long COVID in the United States, 2025, Gourishankar

    I'm keen on this kind of basic epidemiology, I have suspicions that populations are not equally prone to me/cfs even after controlling for pre-existing health outcomes. I have been prone to thinking of me/cfs as a disease mostly of the north sea populations and their diaspora (my forebears...
  11. Murph

    Thesis Sequencing B cell receptor repertoires in human disease: applications in ME/CFS and in experimental malaria infection, 2024, Ryback

    Very nice explanation. You're an asset to this forum, thanks for all your contributions!
  12. Murph

    Antibody reactivity against EBNA1 and GlialCAM differentiates MS patients from healthy controls, 2025,Neda Sattarnezhad et al

    authors: Stanford Journal: PNAS. cases: 650 controls:661. p-values: some very low indeed. tl;dr this study is more likely than most to have found something that is true. That is exciting since what they have found looks relevant and novel.
  13. Murph

    mtDNA deletion [...] with < 10 % heteroplasmy in muscle and isolated complex-V dysfunction misinterpreted as [CFS] over 21-years, 2025, Finsterer+

    This idea of heteroplasmy could also be relevant to mecfs: you need have the genetic problem in only some of your mitochondria for symptoms to develop. It would be an obvious way to distinguish mild moderate and severe.
  14. Murph

    mtDNA deletion [...] with < 10 % heteroplasmy in muscle and isolated complex-V dysfunction misinterpreted as [CFS] over 21-years, 2025, Finsterer+

    Whenever I read about people having problems with the various complexes in the mitochondrial chain I think about Hwang and WASF3. He found in his patient that WASF3 inhibited two complexes joining together to make a supercomplex, which would run more efficiently (and then detected high wasf3 in...
  15. Murph

    Opinion Delayed-Onset Muscle Soreness Begins with a Transient Neural Switch, 2025, Sonkodi

    Got excited by the title, but this is a single author hypothesis paper. To stand up the hypothesis will require a bunch of funding.
  16. Murph

    Genetic Landscape and Mitochondrial Metabolic Dysregulation in Patients Suffering From Severe Long COVID, 2025, Hansen et al

    Doesn't look like too much to me? They checked 94 million genetic variants in patients, found 398 differnt mitochondrial ones in patients, there was one pathway that had variants in five/13 patients, being the Mucin von willebrand pathway.
  17. Murph

    What Mistakes are Being Made in ME Research?

    There's lots of known unknowns in this space like plasma vs serum; pbmcs vs skeletal muscle; sample storage; collecting samples at different times of day, after different amounts of exertion, etc. There's also biological sex and disease duration which muddle things up. And severity. All of...
  18. Murph

    Open TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial

    I emailed Walder and he said : "No drugs yet from the me/cfs study, should be finding some later this year if all goes well". He understands as well as we do that when a drug emerges from this process it is merely a candidate; the process increases the probability that this compound may help...
  19. Murph

    Open TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial

    Look, I also don't think this is the research process most likely to lead to a cure. I do find myself attracted to a philosophical approach that seeks glimmers of light, even amid human and institutional frailty.
  20. Murph

    Open TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial

    There's a small blurb here about the work Deakin are doing on me/cfs: https://med-projects.deakin.edu.au/projects-2023.php yes, they write me/csf some of the time! Like many new studies it's being done by people who've wandered into this field from elsewhere; that lack of deep background...
Back
Top Bottom